MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-05-0005388
Suncare Pharmaceuticals Private Limited - healthcare in Dehradun, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.95 Cr
▲ 2% YoY
Net profit · FY 2024
₹23.98 Lakh
Net margin 8.1%
EBITDA · FY 2024
₹47.19 Lakh
EBITDA margin 16%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹9.5 Lakh
Issued & subscribed
Open charges
₹9.2 Cr
Satisfied ₹2.24 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
5
Provident fund records
About Suncare Pharmaceuticals Private Limited
Data last updated:
Suncare Pharmaceuticals Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the alternative and holistic medicine segment of the healthcare sector. It was incorporated on 18 June 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U31104UT2002PTC017112. Its GSTIN is 05AAHCS2332M1ZB (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹9.5 Lakh. It is led by directors Sanjay Kumar Sikaria and Sandeep Kumar Sikaria.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dehradun, Uttarakhand.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.95 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹23.98 Lakh (net margin 8.1%) and EBITDA of ₹47.19 Lakh (EBITDA margin 16%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.2 Cr and satisfied charges of ₹2.24 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company; 3 cases are pending.
Suncare Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0005388). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website suncareformulations.com.
Company Details of Suncare Pharmaceuticals Private Limited
CIN U31104UT2002PTC017112
Registration Number 017112
Incorporation Date 18 June 2002
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UK-05-0005388
CIN History of Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals has one previous CIN (Corporate Identification Number): U31104WB2002PTC094759. The current CIN is U31104UT2002PTC017112, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U31104UT2002PTC017112 | Current |
| U31104WB2002PTC094759 | Previous |
Recognitions & Rankings of Suncare Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No. 06 Pharmacity, Selaqui, Dehradun, Uttarakhand, India – 248011
- IndustryHealthcare, Alternative & Holistic Medicine
Comprehensive company report
Suncare Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Suncare Pharmaceuticals Private Limited
The main business activities of Suncare Pharmaceuticals are manufacturing and support service to organizations. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other support services to organizations. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Suncare Pharmaceuticals Private Limited FY 2025 filings available
Suncare Pharmaceuticals Private Limited reported revenue of ₹2.95 Cr (up 2% YoY) for FY 2024.
Revenue · FY 2024
₹2.95 Cr ▲ 2%
Net profit · FY 2024
₹23.98 Lakh margin 8.1%
EBITDA · FY 2024
₹47.19 Lakh margin 16%
Compounded Annual Growth Rate (CAGR) of Suncare Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 3%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 108%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 2% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Suncare Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹47.19 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹23.98 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Suncare Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Suncare Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar Sikaria Also directs: Suncare Laboratories LLP, Purbasha Resources Ltd, Suncare Formulations Private Limited and 3 more | Director | 18 Jun 2002 | 24 Years 4 Months | Current |
| Sandeep Kumar Sikaria | Director | 18 Jun 2006 | 20 Years 4 Months | Current |
Peer Comparison of Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Alternative Medicine, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saltvae Pharmaceuticals Private Limited | ₹2.97 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Noida, Uttar Pradesh, India |
| Sirak Pharmaceuticals Private Limited | ₹2.97 Cr (FY 2024) | •••• | •••• | -46.0% | •••• | Hyderabad, Telangana, India |
| Readybio Pharmaceuticals Private Limited | ₹2.96 Cr (FY 2021) | •••• | •••• | 96.0% | •••• | Udaipur, Rajasthan, India |
| Sanbioo Pharmaceuticals Private Limited | ₹2.96 Cr (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Asteron Pharmaceuticals Private Limited | ₹2.95 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Thrissur, Kerala, India |
| Suncare Pharmaceuticals Private Limited this company | ₹2.95 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Dehradun, Uttarakhand, India |
| GMH Pharmaceuticals Pvt Ltd | ₹2.94 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Chandigarh, India |
| CMHP Private Limited | ₹2.93 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Ahmedabad, Gujarat, India |
| Rams Pharmaceuticals Private Limited | ₹2.92 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Thanjavur, Tamil Nadu, India |
| Jalks Pharmaceuticals Private Limited | ₹2.91 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Homoeocare Pediatric Clinics Private Limited | ₹2.91 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Suncare Pharmaceuticals by revenue in the Healthcare industry (Alternative Medicine, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals Private Limited is audited by KHATTAK KOCHHAR & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KHATTAK KOCHHAR & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Suncare Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Suncare Pharmaceuticals Private Limited
Open charges
₹9.2 Cr
Satisfied charges
₹2.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Sep 2020 | Axis Bank Limited | ₹8.5 Cr | Open |
| 19 Aug 2020 | Axis Bank Limited | ₹70 Lakh | Open |
| 09 Oct 2009 | Bank of Baroda | ₹2.24 Cr | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals Private Limited has 3 court cases on record: 1 filed by Suncare Pharmaceuticals, 2 where it is another party. All cases are pending. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Total cases
3
Filed by the company
1
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Commercial suit | Company is another party | Pending |
| District court, Motihari, Bihar | Civil suit | Filed by the company against an individual | Pending |
Premium access
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals Private Limited has 10 MSME Form 1 returns on record between 2019 and 2022, listing 136 overdue payments to 20 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 20)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Devson Impex Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| S. S. Industries | •••• | •••• | •••• |
| Satnam Psyllium Industries | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 10 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals Private Limited has a workforce of 5 employees as of Apr 07, 2024.
Employee count
5
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals Private Limited has 3 board changes on record since 2002: 2 appointments and 1 cessation. The latest: Sushil Kumar Sikaria ceased to be Additional Director on 28 Dec 2020.
Charges
A charge with Axis Bank Limited of Rs. 850.00 Lakh registered on 17 Sep 2020 with Charge ID 100400501 was modified on 28 Oct 2025.
AGM
Suncare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Suncare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Charges
A charge registered on 09 Oct 2009 via Charge ID 10185731 with Bank Of Baroda was fully satisfied on 17 Mar 2021.
Ceased
Sushil Kumar Sikaria ceased to be Additional Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 850.00 Lakh with Charge ID 100400501 was registered on 17 Sep 2020.
Charges
A charge with Axis Bank Limited of Rs. 70.00 Lakh registered on 19 Aug 2020 with Charge ID 100378785 was modified on 17 Sep 2020.
Charges
A charge with Axis Bank Limited amounted to Rs. 70.00 Lakh with Charge ID 100378785 was registered on 19 Aug 2020.
Charges
A charge with Bank Of Baroda amounted to Rs. 224.00 Lakh with Charge ID 10185731 was registered on 09 Oct 2009.
Appointed
Sandeep Kumar Sikaria was appointed as Director.
Appointed
Sanjay Kumar Sikaria was appointed as Director.
Incorporation
18 Jun 2002
Suncare Pharmaceuticals Private Limited was registered on 18 Jun 2002 with Roc Uttarakhand & aged 24 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Suncare Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Suncare Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAHCS2332M1ZB | Uttarakhand | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Suncare Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suncare Pharmaceuticals Private Limited
Suncare Pharmaceuticals is an active private limited company based in Dehradun, Uttarakhand, India. The company works in alternative and holistic medicine, within the healthcare industry. It was incorporated on 18 June 2002 (24+ years old) and is registered under CIN U31104UT2002PTC017112.
Suncare Pharmaceuticals reported revenue of ₹2.95 Cr for FY 2024 (up 2% YoY).
Suncare Pharmaceuticals has 2 current directors:
- Sanjay Kumar Sikaria - Director
- Sandeep Kumar Sikaria - Director
Suncare Pharmaceuticals reported a net profit of ₹23.98 Lakh (net margin 8.1%) and EBITDA of ₹47.19 Lakh (EBITDA margin 16%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Suncare Pharmaceuticals is 3% over three years and 1% over five years. In the latest year (FY 2024) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Suncare Pharmaceuticals is 05AAHCS2332M1ZB, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Suncare Pharmaceuticals is U31104UT2002PTC017112. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suncare Pharmaceuticals has 3 court cases on record: 1 filed by the company. 3 are pending.
Suncare Pharmaceuticals was incorporated on 18 June 2002, making it 24+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Suncare Pharmaceuticals by revenue are Saltvae Pharmaceuticals Private Limited, Sirak Pharmaceuticals Private Limited, Readybio Pharmaceuticals Private Limited, Sanbioo Pharmaceuticals Private Limited, Asteron Pharmaceuticals Private Limited and 5 more, all in the Healthcare industry (Alternative Medicine, Pharmaceuticals).
Sushil Kumar Sikaria ceased to be Additional Director on 28 Dec 2020. Sandeep Kumar Sikaria was appointed as Director on 18 Jun 2006. Sanjay Kumar Sikaria was appointed as Director on 18 Jun 2002.
Yes, Suncare Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-05-0005388).